- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Tianjin Medical University Cancer Institute and Hospital
Total 3809 results
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; 307 Hospital of PLA; Qilu Hospital of Shandong... and other collaboratorsUnknownExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeChina
-
St. Joseph's Hospital and Medical Center, PhoenixNational Cancer Institute (NCI)RecruitingBrain TumorUnited States
-
Wanqi ZhangThe Shandong Institute for Endemic Disease Control and ResearchCompleted
-
Children's Cancer Group, ChinaXiangya Hospital of Central South University; Tongji Hospital; Qilu Hospital... and other collaboratorsActive, not recruiting
-
Capital Medical UniversityCancer Institute and Hospital, Chinese Academy of Medical SciencesSuspended
-
Cancer Institute and Hospital, Chinese Academy...Fujian Cancer HospitalRecruitingEsophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Peking University First Hospital; Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Peking University First HospitalThe Forth Medical Center of PLA General Hospital; Tianjin Orthopedic HospitalRecruitingMalnutrition | Hip Fractures | Elderly Patients | Survival | Perioperative Outcomes | Nutritional InterventionChina
-
Cancer Institute and Hospital, Chinese Academy...Zhejiang Cancer Hospital; Sun Yat-sen University; Henan Cancer Hospital; Tongji... and other collaboratorsUnknown
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; The First Affiliated... and other collaboratorsRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; Affiliated Cancer Hospital &... and other collaboratorsRecruitingEarly-stage | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Beijing Children's HospitalChildren's Hospital of Hebei Province; Tianjin Children's Hospital; Capital Institute... and other collaboratorsUnknown
-
Cancer Institute and Hospital, Chinese Academy...RecruitingChemotherapy Effect | Ampullary AdenomaChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBrain MetastasesChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingGastric Cancer | Diffuse Type CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-small Cell Lung CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | Small-cell Lung Cancer | Lung Squamous Cell CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHepatocellular Carcinoma | Radiotherapy | Narrow MarginChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Colorectal CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRefractory Solid Tumors | Relapsed Solid TumorsChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingCancer | Catheter Complications | Thrombosis, VenousChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingRecurrence | Surgery | Thyroid CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutatedChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCOVID-19 Vaccine | COVID-19 InfectionChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBreast Cancer | Radiotherapy Side EffectChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHead and Neck Cancer | Radiation DermatitisChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRadiotherapy | Rectal Neoplasms MalignantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Nasopharyngeal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingColorectal Cancer Stage IV | Hand and Foot Skin ReactionChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingColorectal Neoplasms MalignantChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSoft Tissue Sarcoma | Radiotherapy Side Effect | Retroperitoneal Sarcoma | Ultra-hypofractionated Radiotherapy | Stereotactic Ablative RadiotherapyChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer | Radiotherapy Side Effect | Oligometastatic Disease | Magnetic Resonance-linac | Stereotactic Ablative RT | Adaptive Radiotherapy | Localised DiseaseChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingCervical Cancer Stage IB1China